I have been a member of the Developmental Therapeutics Group since its inception in 2010. This team of medical oncologists aims to provide access to the newest Phase 1 agents for patients with all types of cancer throughout the Memorial Sloan-Kettering system.
In addition to serving as a reviewer for the Journal of Clinical Oncology as well as Cancer Chemotherapy and Pharmacology, I have authored or co-authored numerous journal articles, reviews, and monographs on first in-human trials of new drugs and targeted therapies for non-small cell lung cancer.
Before Memorial Sloan-Kettering and my joint appointment at Weill Cornell Medical College, I was an attending physician at Lombardi Cancer Center at Georgetown University. My oncology training was conducted at Beth Israel Hospital/Harvard Medical School. I received my medical degree and completed my residency at the University of Manitoba in Winnipeg, Canada.